Timothy Jackson – EURETINA

Podcast

Episode 12: Subretinal Hemorrhage and the TIGER study

In this Journal Club episode, Professors Grazia Pertile and Siegfried Priglinger discuss subretinal hemorrhaging and the developments of the Euretina-sponsored TIGER Study.

Video

Instructional Course 8: Non-Responders in Neovascular AMD – Discussion

Discussion on Instructional Course 8: Non-Responders in Neovascular AMD with Chairperson(s): Irmela Mantel, Maurizio Battaglia Parodi, Francesc March de Ribot

2021 Virtual

Instructional Course 33: Evidence-Based Treatment of Retinal Disease – How Practicing Clinicians Should Read Clinical Trials – Discussion

Discussion on Instructional Course 33: Evidence-Based Treatment of Retinal Disease – How Practicing Clinicians Should Read Clinical Trials with Chairperson(s): Oliver Zeitz, Antonia Joussen

2021 Virtual

Prize Papers 13: New Drug Treatments & Technologies – Discussion

Discussion on Prize Papers 13: New Drug Treatments & Technologies with Chairperson(s): Nicole Eter

2021 Virtual

Symposium Session 18: Tackling Subretinal Hemorrhage – What Is New? – Discussion

Discussion on Symposium Session 18: Tackling Subretinal Hemorrhage – What Is New? with Chairperson(s): Jan Van Meurs, Koen Willekens, Kai Januschowski

2021 Abstracts

A safety study of ONS-5010 for the treatment of wet age-related macular degeneration, diabetic macular oedema and branch retinal vein occlusion.

Author: Timothy Jackson (United Kingdom)

Co-authors: Allen Hu, Jeremiah Brown, Mark Humayun